What you should know:
1. PTC entered into a 15-year lease. The space includes a biologics production facility, research spaces and operations buildings.
2. PTC will develop the biologics facility to support its gene therapy production capabilities. The site is pivoting its current production schedule to create materials to support PTC’s preclinical and clinical programs.
3. PTC also intends to relocate its research operations to the site.
More articles on biologics:
Why Dr. Dominic Thomas Kleinhenz joined University Orthopedics and the biggest obstacle in spine
Dr. Stephen Hochschuler: Future trends in spine – telemedicine, robotics, AI & more
Dr. Christopher Kager: The standout spine procedure in his career, future of biologics & more
